Literature DB >> 7640286

Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene.

I Talianidis1, A Tambakaki, J Toursounova, V I Zannis.   

Abstract

Footprinting analysis of the human apoCIII promoter identified a set of four proximal (A-D) and six distal (E-J) regulatory elements between nucleotides -792 and -25 [Ogami, K., et al. (1990) J. Biol. Chem. 265, 9808-9815]. The distal regulatory elements of the apoCIII gene increase by 10-fold the strength of the homologous as well as of heterologous proximal promoters. Required for such transcriptional enhancement is the presence of an intact hormone response element (HRE) on the proximal promoter which binds a variety of nuclear hormone receptors. To understand the mechanism of this transcriptional activation, we identified the nature and the importance of the factors which bind to the upstream regulatory elements of the apoCIII promoter by DNA binding, competition, supershift, and transient transfection assays. These analyses showed that the upstream apoCIII promoter contains multiple binding sites for the ubiquitous transcription factor SP1, which recognizes the regulatory elements F, H, and I. The regulatory element G represents a specialized HRE which is recognized by the orphan receptors ARP-1 and EAR-3 but not by HNF-4. A single activity designated CIII J1 binds to the regulatory element J. The same or a similar activity binds as a minor component to the regulatory elements F and I where SP1 is the predominant binding activity. Finally, a minor activity designated CIII 15 binds to the regulatory element I.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640286     DOI: 10.1021/bi00032a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins.

Authors:  L Suaud; P Formstecher; B Laine
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression.

Authors:  E Ktistaki; I Talianidis
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

3.  Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway.

Authors:  Varvara Nikolaidou-Neokosmidou; Vassilis I Zannis; Dimitris Kardassis
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

4.  The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice.

Authors:  S Georgopoulos; H Y Kan; C Reardon-Alulis; V Zannis
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

5.  The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region.

Authors:  J M Lacorte; E Fourniat; D Pastier; J Chambaz; A Ribeiro; P Cardot
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  Co-operation of the transcription factor hepatocyte nuclear factor-4 with Sp1 or Sp3 leads to transcriptional activation of the human haem oxygenase-1 gene promoter in a hepatoma cell line.

Authors:  Shigeru Takahashi; Naomi Matsuura; Takako Kurokawa; Yuji Takahashi; Takashi Miura
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

7.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20

8.  Identification of key genes associated with the human abdominal aortic aneurysm based on the gene expression profile.

Authors:  Xudong Chen; Chengfei Zheng; Yunjun He; Lu Tian; Jianhui Li; Donglin Li; Wei Jin; Ming Li; Shusen Zheng
Journal:  Mol Med Rep       Date:  2015-10-15       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.